Works by Katakami, Nobuyuki


Results: 78
    1
    2

    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).

    Published in:
    2018
    By:
    • Akito Hata;
    • Nobuyuki Katakami;
    • Mototsugu Shimokawa;
    • Tetsuya Mitsudomi;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawa;
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Shimokawa, Mototsugu;
    • Mitsudomi, Tetsuya;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    3

    Phase II study of carboplatin plus weekly paclitaxel with bevacizumab for non-squamous, non-small cell lung cancer with idiopathic interstitial pneumonia (Hanshin Cancer Group IP002).

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 1, p. 67, doi. 10.1093/jjco/hyae132
    By:
    • Katakami, Nobuyuki;
    • Nagata, Kazuma;
    • Nakakura, Akiyoshi;
    • Okamoto, Tadashi;
    • Kaneda, Toshihiko;
    • Oki, Masahide;
    • Watanabe, Kana;
    • Tokito, Takaaki;
    • Amano, Yoshihiro;
    • Tamiya, Motohiro;
    • Morita, Satoshi;
    • Hatachi, Yukimasa
    Publication type:
    Article
    4

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    5

    A Phase II Study of Pemetrexed in Chemotherapy-naïve Elderly Patients Aged ≥75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003).

    Published in:
    Japanese Journal of Clinical Oncology, 2013, v. 43, n. 12, p. 1184, doi. 10.1093/jjco/hyt159
    By:
    • Hattori, Yoshihiro;
    • Iwasaku, Masahiro;
    • Satouchi, Miyako;
    • Nishiyama, Akihiro;
    • Korogi, Yohei;
    • Otsuka, Kojiro;
    • Fujita, Shiro;
    • Katakami, Nobuyuki;
    • Mori, Masahide;
    • Nishino, Kazumi;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial.

    Published in:
    Investigational New Drugs, 2006, v. 24, n. 2, p. 151, doi. 10.1007/s10637-006-5937-2
    By:
    • Toshiyuki Sawa;
    • Takashi Yana;
    • Minoru Takada;
    • Takahiko Sugiura;
    • Shinzoh Kudoh;
    • Tadashi Kamei;
    • Takeshi Isobe;
    • Hidehiko Yamamoto;
    • Soichiro Yokota;
    • Nobuyuki Katakami;
    • Yuji Tohda;
    • Akira Kawakami;
    • Yoichi Nakanishi;
    • Yutaka Ariyoshi
    Publication type:
    Article
    13
    14

    Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.

    Published in:
    2016
    By:
    • Takayama, Koichi;
    • Atagi, Shinji;
    • Imamura, Fumio;
    • Tanaka, Hiroshi;
    • Minato, Koichi;
    • Harada, Toshiyuki;
    • Katakami, Nobuyuki;
    • Yokoyama, Takuma;
    • Yoshimori, Kozo;
    • Takiguchi, Yuichi;
    • Hataji, Osamu;
    • Takeda, Yuichiro;
    • Aoe, Keisuke;
    • Kim, Young;
    • Yokota, Soichiro;
    • Tabeta, Hiroshi;
    • Tomii, Keisuke;
    • Ohashi, Yasuo;
    • Eguchi, Kenji;
    • Watanabe, Koshiro
    Publication type:
    journal article
    15
    16

    Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.

    Published in:
    Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05626-2
    By:
    • Arasada, Rajeswara Rao;
    • Shilo, Konstantin;
    • Yamada, Tadaaki;
    • Zhang, Jianying;
    • Yano, Seiji;
    • Ghanem, Rashelle;
    • Wang, Walter;
    • Takeuchi, Shinji;
    • Fukuda, Koji;
    • Katakami, Nobuyuki;
    • Tomii, Keisuke;
    • Ogushi, Fumitaka;
    • Nishioka, Yasuhiko;
    • Talabere, Tiffany;
    • Misra, Shrilekha;
    • Duan, Wenrui;
    • Fadda, Paolo;
    • Rahman, Mohammad A.;
    • Nana-Sinkam, Patrick;
    • Evans, Jason
    Publication type:
    Article
    17

    Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis.

    Published in:
    Clinical & Experimental Metastasis, 2014, v. 31, n. 5, p. 543, doi. 10.1007/s10585-014-9648-3
    By:
    • Fujimoto, Daichi;
    • Ueda, Hiroyuki;
    • Shimizu, Ryoko;
    • Kato, Ryoji;
    • Otoshi, Takehiro;
    • Kawamura, Takahisa;
    • Tamai, Koji;
    • Shibata, Yumi;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Katakami, Nobuyuki;
    • Tomii, Keisuke
    Publication type:
    Article
    18

    Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
    By:
    • Katakami, Nobuyuki;
    • Yokoyama, Toshihide;
    • Morita, Satoshi;
    • Okamoto, Tatsuro;
    • Urata, Yoshiko;
    • Hattori, Yoshihiro;
    • Iwamoto, Yasuo;
    • Sato, Yuki;
    • Ikeda, Norihiko;
    • Takahashi, Toshiaki;
    • Daga, Haruko;
    • Oguri, Tetsuya;
    • Fujisaka, Yasuhito;
    • Nishino, Kazumi;
    • Sugawara, Shunichi;
    • Kozuki, Toshiyuki;
    • Oki, Masahide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    19

    Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2216, doi. 10.1007/s10147-021-02012-9
    By:
    • Yamaguchi, Masafumi;
    • Tada, Hirohito;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Yokoi, Kohei;
    • Katakami, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Oda, Makoto;
    • Ohta, Mitsunori;
    • Sawa, Toshiyuki;
    • Yamashita, Motohiro;
    • Iked, Norihiko;
    • Saka, Hideo;
    • Higashiyama, Masahiko;
    • Nomori, Hiroaki;
    • Semba, Hiroshi;
    • Negoro, Shunichi;
    • Chiba, Yasutaka;
    • Shimokawa, Mototsugu;
    • Fukuoka, Masahiro
    Publication type:
    Article
    20

    Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.

    Published in:
    International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0
    By:
    • Yamamoto, Noboru;
    • Goto, Koichi;
    • Nishio, Makoto;
    • Chikamori, Kenichi;
    • Hida, Toyoaki;
    • Maemondo, Makoto;
    • Katakami, Nobuyuki;
    • Kozuki, Toshiyuki;
    • Yoshioka, Hiroshige;
    • Seto, Takashi;
    • Tajima, Kosei;
    • Tamura, Tomohide
    Publication type:
    Article
    21
    22

    Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial.

    Published in:
    International Journal of Clinical Oncology, 2015, v. 20, n. 1, p. 198, doi. 10.1007/s10147-014-0697-z
    By:
    • Shimoyama, Naohito;
    • Gomyo, Ikuo;
    • Katakami, Nobuyuki;
    • Okada, Masakuni;
    • Yukitoshi, Nobuyuki;
    • Ohta, Eri;
    • Shimoyama, Megumi
    Publication type:
    Article
    23
    24
    25

    Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan.

    Published in:
    Cancer (0008543X), 1996, v. 77, n. 1, p. 63, doi. 10.1002/(SICI)1097-0142(19960101)77:1<63::AID-CNCR12>3.0.CO;2-6
    By:
    • Katakami, Nobuyuki;
    • Takada, Minoru;
    • Negoro, Shunichi;
    • Ota, Katsuyasu;
    • Fujita, Jiro;
    • Furuse, Kiyoyuki;
    • Ariyoshi, Yutaka;
    • Ikegami, Harumichi;
    • Fukuoka, Masahiro
    Publication type:
    Article
    26
    27

    Randomized Phase H Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus lrinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01.

    Published in:
    Clinical Lung Cancer, 2025, v. 26, n. 1, p. 1, doi. 10.1016/j.cllc.2024.09.004
    By:
    • Hiroshige Yoshioka;
    • Tadashi Ishida;
    • Shinji Atagi;
    • Akihiro Tamiya;
    • Takashi Nishimura;
    • Yasuo Iwamoto;
    • Masashi Kanehara;
    • Young Hak Kim;
    • Yohei Korogi;
    • Keisuke Tomii;
    • Nobuyuki Katakami;
    • Kiyoshi Komuta;
    • Masanori Nishikawa;
    • Akihiko Gemma;
    • Kenichi Yamaki;
    • Masaaki Kawahara;
    • Chisato Miyakoshi;
    • Tadashi Mio
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patients.

    Published in:
    Molecular & Clinical Oncology, 2014, v. 2, n. 3, p. 454, doi. 10.3892/mco.2014.249
    By:
    • JUMPEI TAKESHITA;
    • KATSUHIRO MASAGO;
    • SHIRO FUJITA;
    • AKITO HATA;
    • REIKO KAJI;
    • TAKAHISA KAWAMURA;
    • KOJI TAMAI;
    • TAKESHI MATSUMOTO;
    • KAZUMA NAGATA;
    • KYOKO OTSUKA;
    • ATSUSHI NAKAGAWA;
    • KOJIRO OTSUKA;
    • KEISUKE TOMII;
    • TAKASHI SHINTANI;
    • KENJI TAKAYAMA;
    • MASAKI KOKUBO;
    • NOBUYUKI KATAKAMI
    Publication type:
    Article
    39
    40

    Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).

    Published in:
    2018
    By:
    • Katakami, Nobuyuki;
    • Uchino, Junji;
    • Yokoyama, Takuma;
    • Naito, Tateaki;
    • Kondo, Masashi;
    • Yamada, Kouzo;
    • Kitajima, Hiromoto;
    • Yoshimori, Kozo;
    • Sato, Kazuhiro;
    • Saito, Hiroshi;
    • Aoe, Keisuke;
    • Tsuji, Tetsuya;
    • Takiguchi, Yuichi;
    • Takayama, Koichi;
    • Komura, Naoyuki;
    • Takiguchi, Toru;
    • Eguchi, Kenji
    Publication type:
    journal article
    41

    Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations.

    Published in:
    2013
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Yoshioka, Hiroshige;
    • Takeshita, Jumpei;
    • Tanaka, Kosuke;
    • Nanjo, Shigeki;
    • Fujita, Shiro;
    • Kaji, Reiko;
    • Imai, Yukihiro;
    • Monden, Kazuya;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Tachikawa, Ryo;
    • Tomii, Keisuke;
    • Kunimasa, Kei;
    • Iwasaku, Masahiro;
    • Nishiyama, Akihiro;
    • Ishida, Tadashi;
    • Nishimura, Yoshihiro
    Publication type:
    Journal Article
    42

    Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 24, p. 4325, doi. 10.1002/cncr.28364
    By:
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Yoshioka, Hiroshige;
    • Takeshita, Jumpei;
    • Tanaka, Kosuke;
    • Nanjo, Shigeki;
    • Fujita, Shiro;
    • Kaji, Reiko;
    • Imai, Yukihiro;
    • Monden, Kazuya;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Tachikawa, Ryo;
    • Tomii, Keisuke;
    • Kunimasa, Kei;
    • Iwasaku, Masahiro;
    • Nishiyama, Akihiro;
    • Ishida, Tadashi;
    • Nishimura, Yoshihiro
    Publication type:
    Article
    43
    44
    45

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    46

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    47

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    48

    Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer.

    Published in:
    Cancer Science, 2020, v. 111, n. 2, p. 561, doi. 10.1111/cas.14260
    By:
    • Takeuchi, Shinji;
    • Hase, Tetsunari;
    • Shimizu, Shinobu;
    • Ando, Masahiko;
    • Hata, Akito;
    • Murakami, Haruyasu;
    • Kawakami, Takahiro;
    • Nagase, Katsuhiko;
    • Yoshimura, Kenichi;
    • Fujiwara, Tadami;
    • Tanimoto, Azusa;
    • Nishiyama, Akihiro;
    • Arai, Sachiko;
    • Fukuda, Koji;
    • Katakami, Nobuyuki;
    • Takahashi, Toshiaki;
    • Hasegawa, Yoshinori;
    • Ko, Tun Kiat;
    • Ong, S. Tiong;
    • Yano, Seiji
    Publication type:
    Article
    49
    50